Skip to main content
. 2022 May 6;14(5):1000. doi: 10.3390/pharmaceutics14051000

Figure 5.

Figure 5

In vivo studies of KB tumor-bearing mice before and 24 h after administering of MZF@TPGS formulations. (A) T1-weighted and (B) T2-weighted animal MR images taken by a 7 T animal MR scanner. (C) Analysis of the photo brightness intensity using ImageJ. (* p < 0.05) (D) The images of H&E staining and Prussian blue staining of liver and tumor sections from the KB tumor-bearing mice 24 h. The arrows indicate iron staining.